Citadel Advisors’s Ingredion INGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$338K Buy
+3,000
New +$344K ﹤0.01% 10198
2025
Q4
Sell
-6,900
Closed -$843K 13330
2025
Q3
$843K Buy
6,900
+4,000
+138% +$516K ﹤0.01% 7916
2025
Q2
$393K Sell
2,900
-3,800
-57% -$513K ﹤0.01% 9185
2025
Q1
$906K Sell
6,700
-1,400
-17% -$185K ﹤0.01% 7185
2024
Q4
$1.11M Sell
8,100
-700
-8% -$98.5K ﹤0.01% 6781
2024
Q3
$1.21M Buy
8,800
+3,900
+80% +$496K ﹤0.01% 6476
2024
Q2
$562K Sell
4,900
-3,200
-40% -$370K ﹤0.01% 7825
2024
Q1
$946K Buy
8,100
+600
+8% +$67.6K ﹤0.01% 7026
2023
Q4
$814K Sell
7,500
-1,700
-18% -$171K ﹤0.01% 7097
2023
Q3
$905K Buy
9,200
+2,100
+30% +$218K ﹤0.01% 6792
2023
Q2
$752K Sell
7,100
-12,100
-63% -$1.29M ﹤0.01% 7048
2023
Q1
$1.95M Sell
19,200
-100
-0.5% -$9.98K ﹤0.01% 5424
2022
Q4
$1.89M Buy
+19,300
New +$1.78M ﹤0.01% 5597
2022
Q3
Sell
-4,400
Closed -$388K 13083
2022
Q2
$388K Sell
4,400
-3,000
-41% -$269K ﹤0.01% 9206
2022
Q1
$645K Sell
7,400
-5,900
-44% -$534K ﹤0.01% 8775
2021
Q4
$1.28M Sell
13,300
-200
-1% -$19.2K ﹤0.01% 7292
2021
Q3
$1.2M Sell
13,500
-3,300
-20% -$291K ﹤0.01% 7672
2021
Q2
$1.52M Buy
16,800
+4,200
+33% +$392K ﹤0.01% 7286
2021
Q1
$1.13M Buy
12,600
+4,600
+58% +$393K ﹤0.01% 7794
2020
Q4
$629K Sell
8,000
-4,500
-36% -$347K ﹤0.01% 7717
2020
Q3
$946K Buy
12,500
+8,100
+184% +$658K ﹤0.01% 6140
2020
Q2
$365K Sell
4,400
-1,500
-25% -$123K ﹤0.01% 7596
2020
Q1
$445K Sell
5,900
-2,400
-29% -$206K ﹤0.01% 6651
2019
Q4
$771K Sell
8,300
-4,100
-33% -$344K ﹤0.01% 6068
2019
Q3
$1.01M Buy
12,400
+3,400
+38% +$270K ﹤0.01% 5571
2019
Q2
$742K Buy
9,000
+2,900
+48% +$249K ﹤0.01% 6196
2019
Q1
$578K Sell
6,100
-9,300
-60% -$879K ﹤0.01% 6549
2018
Q4
$1.41M Buy
15,400
+7,700
+100% +$771K ﹤0.01% 4742
2018
Q3
$808K Sell
7,700
-12,400
-62% -$1.27M ﹤0.01% 5914
2018
Q2
$2.23M Buy
20,100
+5,500
+38% +$647K ﹤0.01% 3937
2018
Q1
$1.88M Buy
14,600
+6,700
+85% +$896K ﹤0.01% 3823
2017
Q4
$1.1M Buy
7,900
+2,100
+36% +$277K ﹤0.01% 4524
2017
Q3
$700K Buy
5,800
+2,600
+81% +$317K ﹤0.01% 4842
2017
Q2
$381K Sell
3,200
-1,700
-35% -$202K ﹤0.01% 5523
2017
Q1
$590K Sell
4,900
-13,200
-73% -$1.61M ﹤0.01% 4763
2016
Q4
$2.26M Sell
18,100
-3,600
-17% -$455K ﹤0.01% 2805
2016
Q3
$2.89M Sell
21,700
-5,000
-19% -$668K ﹤0.01% 2544
2016
Q2
$3.46M Buy
26,700
+21,100
+377% +$2.46M ﹤0.01% 2165
2016
Q1
$598K Buy
5,600
+3,100
+124% +$309K ﹤0.01% 4153
2015
Q4
$240K Sell
2,500
-200
-7% -$19K ﹤0.01% 5545
2015
Q3
$236K Sell
2,700
-2,400
-47% -$206K ﹤0.01% 5917
2015
Q2
$407K Sell
5,100
-6,300
-55% -$506K ﹤0.01% 5289
2015
Q1
$887K Buy
11,400
+4,800
+73% +$393K ﹤0.01% 4080
2014
Q4
$560K Sell
6,600
-7,600
-54% -$604K ﹤0.01% 4573
2014
Q3
$1.08M Buy
14,200
+3,800
+37% +$295K ﹤0.01% 3619
2014
Q2
$780K Buy
10,400
+6,000
+136% +$436K ﹤0.01% 3814
2014
Q1
$300K Buy
4,400
+1,400
+47% +$91.9K ﹤0.01% 5023
2013
Q4
$205K Sell
3,000
-1,100
-27% -$74.4K ﹤0.01% 4999
2013
Q3
$271K Sell
4,100
-16,500
-80% -$1.08M ﹤0.01% 4469
2013
Q2
$1.35M Buy
+20,600
New +$1.45M ﹤0.01% 2881

Other funds holding INGR

Citadel Advisors's INGR Position: Q1 2026 in Review

Citadel Advisors increased its Ingredion (INGR) stake by 785% in Q1 2026, buying an estimated $24.3M and bringing the position to 238,542 shares worth $26.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1971.

Citadel Advisors first reported a position in INGR in Q2 2013 and has held it in 50 quarters since. The position peaked at $46M in Q2 2017. 659 funds tracked by Wall St. Rank hold INGR as of Q1 2026.

  • Citadel Advisors held 238,542 shares of Ingredion worth $26.9M as of Q1 2026.
  • Citadel Advisors bought 211,597 Ingredion shares in Q1 2026, an estimated $24.3M.
  • Ingredion made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #1971 holding.
  • Citadel Advisors first reported a position in Ingredion in Q2 2013 and has held it in 50 quarters since.
  • Citadel Advisors's Ingredion position peaked at $46M in Q2 2017.
  • 659 funds tracked by Wall St. Rank held Ingredion as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.